BioNTech SE (BNTX) EBT (2018 - 2026)

BioNTech SE has disclosed EBT across 9 years of filings, most recently posting -$998.1 million for Q2 2026.

• In Q2 2026, EBT fell 118.96% year-over-year to -$998.1 million; the TTM figure through Jun 2026 stood at -$1.9 billion (down 343.49% YoY), while the FY2025 annual figure was -$1.2 billion, down 68.9% from the prior year.
• EBT came in at -$998.1 million for Q2 2026 at BioNTech SE, down from -$665.1 million in the prior quarter.
• In the past five years, EBT ranged from a high of $5.6 billion in Q1 2022 to a low of -$998.1 million in Q2 2026.
• Average EBT over 5 years is $640.2 million, with a median of $101.6 million recorded in 2024.
• Year-over-year, EBT soared 184.3% in 2022 and plunged 182.24% in 2025.
• Over 5 years, EBT stood at $3.2 billion in 2022, then plunged by 77.95% to $713.6 million in 2023, then tumbled by 54.89% to $321.9 million in 2024, then sank by 182.24% to -$264.7 million in 2025, then sank by 277.07% to -$998.1 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$998.1 million in Q2 2026, -$665.1 million in Q1 2026, and -$264.7 million in Q4 2025.